Press Releases about Pfizer
Biosimilars Market Worth $44.7 Billion by 2026 - Exclusive Report by MarketsandMarkets™
October 08, 2021
Via SBWire
Topics
Intellectual Property
Exposures
Intellectual Property
Via SBWire
Via Newswire.com
Buriram Massage Studio Owner Receives Pfizer – BioNTech Covid-19 Vaccination 3rd Booster Shot
October 04, 2021
Via Zexprwire
Exposures
COVID-19
Global Biosimilars Industry Analysis Report 2021:Pfizer, Novartis, Biocon
September 30, 2021
Via SBWire
Why Some Experts Say for an Effective COVID Vaccine, Look Beyond Antibodies to T-Cells
September 28, 2021
Exposures
COVID-19
Pfizer Starts Study of mRNA-Based Next Generation Flu Vaccine Program
September 27, 2021
From Pfizer Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|